Literature DB >> 9106736

Brain microvascular endothelial cells and leukocytes derived from patients with multiple sclerosis exhibit increased adhesion capacity.

J Lou1, M Chofflon, C Juillard, Y Donati, N Mili, C A Siegrist, G E Grau.   

Abstract

The adhesion properties of brain microvascular endothelial cells (MVEC) and leukocytes derived from patients with multiple sclerosis (MS) were investigated. Leukocytes and brain MVEC from MS patients exhibited significantly higher adhesion capacity than the same cells isolated from normal donors. Flow cytometry showed that MS-derived brain MVEC constitutively expressed higher levels of ICAM-1 and contained an increased proportion of MHC class II positive cells than normal brain MVEC. In contrast, no difference was seen for vascular cell adhesion molecule-1 and endothelial cell leukocyte adhesion molecule-1. Circulating leukocytes from MS patients expressed higher levels of LFA-1, a ligand of intercellular adhesion molecule-1 (ICAM-1), than did normal leukocytes. The data presented here suggest that the ICAM-1/LFA-1 interaction may determine cytoadherence of leukocytes to brain MVEC in MS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9106736     DOI: 10.1097/00001756-199702100-00010

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  10 in total

1.  Expression of thyroid-stimulating hormone receptors and thyroglobulin in limbic regions in the adult human brain.

Authors:  Meleshni Naicker; Strinivasen Naidoo
Journal:  Metab Brain Dis       Date:  2017-08-03       Impact factor: 3.584

2.  Bipolar limbic expression of auto-immune thyroid targets: thyroglobulin and thyroid-stimulating hormone receptor.

Authors:  Meleshni Naicker; Nathlee Abbai; Strinivasen Naidoo
Journal:  Metab Brain Dis       Date:  2019-06-13       Impact factor: 3.584

3.  Effect of Insulin Receptor-Knockdown on the Expression Levels of Blood-Brain Barrier Functional Proteins in Human Brain Microvascular Endothelial Cells.

Authors:  Hinako Nagano; Shingo Ito; Takeshi Masuda; Sumio Ohtsuki
Journal:  Pharm Res       Date:  2021-11-22       Impact factor: 4.200

Review 4.  Pharmacological targeting of ICAM-1 signaling in brain endothelial cells: potential for treating neuroinflammation.

Authors:  Patric Turowski; Peter Adamson; John Greenwood
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

5.  Breakdown of the blood-brain barrier during tick-borne encephalitis in mice is not dependent on CD8+ T-cells.

Authors:  Daniel Růžek; Jiří Salát; Sunit K Singh; Jan Kopecký
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

Review 6.  Nanoparticles for brain drug delivery.

Authors:  Massimo Masserini
Journal:  ISRN Biochem       Date:  2013-05-21

Review 7.  Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA; Leukothera®): Mechanisms of Action and Therapeutic Applications.

Authors:  Brian A Vega; Benjamin A Belinka; Scott C Kachlany
Journal:  Toxins (Basel)       Date:  2019-08-26       Impact factor: 4.546

8.  Suppression of experimental autoimmune encephalomyelitis by extracellular adherence protein of Staphylococcus aureus.

Authors:  Changping Xie; Pilar Alcaide; Brian V Geisbrecht; Darius Schneider; Mathias Herrmann; Klaus T Preissner; Francis W Luscinskas; Triantafyllos Chavakis
Journal:  J Exp Med       Date:  2006-04-03       Impact factor: 14.307

9.  FRET based quantification and screening technology platform for the interactions of leukocyte function-associated antigen-1 (LFA-1) with intercellular adhesion molecule-1 (ICAM-1).

Authors:  Sandeep Chakraborty; David Núñez; Shih-Yang Hu; María Pilar Domingo; Julian Pardo; Artashes Karmenyan; Arthur Chiou
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240

Review 10.  The effect of insomnia on development of Alzheimer's disease.

Authors:  Shaghayegh Sadeghmousavi; Mahsa Eskian; Farzaneh Rahmani; Nima Rezaei
Journal:  J Neuroinflammation       Date:  2020-10-06       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.